FDA and PDA hold an annual Joint Regulatory Conference, which provides a unique opportunity for participants to engage with FDA representatives and industry experts in face-to-face dialogue. Each year, the conference focuses on the “current issues affecting the industry,” and explores different strategies to expedite the development and continuous improvement of safe and effective medical products.
During the conference participants will have the chance “to discuss the foundations, emerging technologies, and innovations in regulatory science, as well as the current quality and compliance areas of concerns.” Participants will hear from a number of speakers from the industry as well as representatives from the Agency who will delve into the “requirements and best practices to consider while implementing robust quality systems in order to deliver the best quality product.” The topics that will be discussed throughout a series of sessions and meetings include, but are not limited to:
The 2016 FDA-PDA Joint Regulatory Conference will be held from September 12 to 14, 2016 at the Renaissance Washington DC Downtown Hotel. Registration is required, and those interested in attending the conference are encouraged to register as soon as possible, as space is limited and on a first come first served basis. On-site registration will be offered as space allows and will begin at 1pm on September 11, 2016, and at 7am from September 12 through 14, 2016.